BioPharma Credit PLC (LON:BPCR)

BioPharma Credit Revenue

In the year 2025, BioPharma Credit had annual revenue of $157.75M USD with 5.14% growth. BioPharma Credit had revenue of $73.97M in the half year ending December 31, 2025, with 29.27% growth.

• Revenue: $157.75M
• Revenue Growth: +5.14%
• P/S Ratio: 6.75
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 791.57M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	157.75M	7.72M	5.14%
Dec 31, 2024	150.03M	14.29M	10.53%
Dec 31, 2023	135.74M	-82.43M	-37.78%
Dec 31, 2022	218.17M	114.29M	110.02%
Dec 31, 2021	103.88M	-6.14M	-5.58%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jun 15, 2026

Data Sources Report a data error